JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (10): 1-8,28.doi: 10.6040/j.issn.1671-7554.0.2014.273
SUN Hui, ZHAO Lei, ZHEN Xi, WANG Shasha, HUANG Shanying, HE Hong, HU Qin
CLC Number:
| [1] Juutilainen A, Lehto S, Ronnemaa T, et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects[J]. Diabetes Care, 2008, 31(4): 714-719. [2] Grundy S M, Howard B, Smith S Jr, et al. Prevention conference VI: Diabetes and cardiovascular disease executive summary conference proceeding for healthcare professionals from a special writing group of the American heart association[J]. Circulation, 2002, 105(18): 2231-2239. [3] Toso C, Emamaullee J A, Merani S, et al. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes[J]. Diabetologia, 2008, 51(11): 1937-1946. [4] Tse J, Martin-McNaulty B, Halks-Miller M, et al. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol[J]. Atherosclerosis, 1999, 144(2): 303-313. [5] Jawień J, Nastałek P, Korbut R. Mouse models of experimental atherosclerosis[J]. J Physiol Pharmacol, 2004, 55(3): 503-517. [6] Hsueh W, Abel E D, Breslow J L, et al. Recipes for creating animal models of diabetic cardiovascular disease[J]. Circ Res, 2007, 100(10): 1415-1427. [7] Nakashima Y, Plump A S, Raines E W, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree[J]. Arterioscler Thromb, 1994, 14(1): 133-140. [8] Abel E D, Kaulbach H C, Tian R, et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart[J]. J Clin Invest, 1999, 104(12): 1703-1714. [9] Gallagher E J, Sun H, Kornhauser C, et al. The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes[J]. Diabetes Metab Res Rev, 2014, 30(3): 191-200. [10] Naveiras O, Nardi V, Wenzel P L, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment[J]. Nature, 2009, 460(7252): 259-264. [11] Kadoglou N P, Moustardas P, Kapelouzou A, et al. The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis[J]. Eur J Histochem, 2013, 57(1): 3. [12] Goldberg I J, Dansky H M. Diabetic vascular disease: an experimental objective[J]. Arterioscler Thromb Vasc Biol, 2006, 26(8): 1693-701. [13] Tong C, Morrison A, Yan X, et al. Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes[J]. J Diabetes, 2010, 2(4): 267-274. [14] Kunjathoor V V, Wilson D L, LeBoeuf R C. Increased atherosclerosis in streptozotocin-induced diabetic mice[J]. J Clin Invest, 1996, 97(7): 1767-1773. [15] Candido R, Jandeleit-Dahm K A, Cao Z, et al. Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E-Deficient Mice[J]. Circulation, 2002, 106(2): 246-253. [16] Koïtka A, Cao Z, Koh P, et al. Angiotensin Ⅱ subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes[J]. Diabetologia, 2010, 53(3): 584-592. [17] Shen X, Bornfeldt K E. Mouse models for studies of cardiovascular complications of type 1 diabetes[J]. Ann N Y Acad Sci, 2007, 1103: 202-217. [18] Libby P. Inflammation in atherosclerosis[J]. Nature, 2002, 420(6917): 868-874. [19] Göran K, Hansson P L, Yan Usa Z. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis[J]. Circulation Research, 2002, 91(4): 281-291. [20] van der Wal A C, Becker A E, van der Loos C M, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology[J]. Circulation, 1994, 89(1): 36-44. [21] Boring L, Gosling J, Cleary M, et al. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis[J]. Nature, 1998, 394(6696): 894-897. [22] Huber S A, Sakkinen P, Conze D, et al.Interleukin-6 exacerbates early atherosclerosis in mice[J]. Arterioscler Thromb Vasc Biol, 1999, 19(10): 2364-2367. [23] Wong N D, Patao C, Malik S, et al. Preventable coronaryheart disease events from control of cardiovascular risk factors in US adults with diabetes (Projections from Utilizing the UKPDS Risk Engine)[J]. Am J Cardiol, 2014, 113(8): 1356-1361. [24] Sherry C L, O'Connor J C, Kramer J M, et al. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK[J]. J Immunol, 2007, 178(2): 663-670. [25] Gough P J, Gomez I G, Wille P T, et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice[J]. J Clin Invest, 2006, 116(1): 59-69. [26] Ding S, Zhang M, Zhao Y, et al. The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke[J]. Am J Med Sci, 2008, 336(1): 27-31. [27] Matsumura S, Iwanaga S, Mochizuki S, et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice[J]. J Clin Invest, 2005, 115(3): 599-609. [28] Newby A C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates[J]. Cardiovasc Res, 2006, 69(3): 614-624. [29] Allaire E, Forough R, Clowes M, et al. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model[J]. J Clin Invest, 1998, 102(7): 1413-1420. [30] Rouis M, Adamy C, Duverger N, et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E–deficient mice[J]. Circulation, 1999, 100(5): 533-540. [31] Lemaître V, Soloway P D, D'Armiento. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1[J]. Circulation, 2003, 107(2): 333-338. |
| [1] | DUAN Yingzhu, DONG Bo, YU Rui. Mendelian randomization study on the association of intrinsic emotions with coronary atherosclerosis risk in patients with rheumatoid arthritis [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 63-71. |
| [2] | LI Xiping, QIU Mei, HUANG Ruifeng, LIN Huihui, LIU Sisi, LUO Hongying, WANG Yuyue, WANG Min, YANG Xiaotong. Research progress on the mechanism of berberines anti-atherosclerosis effects based on the synergistic effect of lipid deposition inhibition and metabolic clearance [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 77-83. |
| [3] | MENG Xiaomei, HAO Yaping, WANG Liang, YU Xiao, TANG Yuxiao. Correlation between the levels of serum Isthmin1, Gremlin2 and retinopathy in type 2 diabetic patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 102-107. |
| [4] | WANG Mengxing, XUE Fuzhong, YANG Fan. Blood glucose concentration prediction method for type 1 diabetes mellitus based on multi-modal cross-attention mechanism fusion [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 41-50. |
| [5] | SHEN Lujia, LU Tianwei, GONG Weiming, ZHAO Yansong, WANG Shukang, YUAN Zhongshang. Application of metabolomic risk score in predicting cardiovascular outcomes in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 69-78. |
| [6] | CHEN Yingying, WANG Lu, HU Xifeng, ZHU Gaopei, XUE Fuzhong. A Bayesian network-based risk prediction study of stroke in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 94-102. |
| [7] | CHEN Xujun, HE Guowei. Focus on further more use of arterial grafts in coronary artery bypass grafting in patients with coronary heart disease in China [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 1-5. |
| [8] | LU Shengxun, XING Yachuang, LUO Junhui, LIU Jie, HE Houle, WANG Zhiqiang, ZHANG Na. Diabetic patients arterial grafts in coronary artery bypass grafting: current research status [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 33-39. |
| [9] | DU Aijia, ZHANG Man, CHEN He, WANG Lixin, SHANG Yingshu. miR-1270-targeted regulation of angiopoietin-like protein 7 inhibits macrophage inflammation and lipid accumulation [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 1-9. |
| [10] | LIN Xiaoqian, FENG Maoyan, MOU Zheng. Pharmaceutical characteristics and clinical utility of dipeptidyl peptidase-4 inhibitors [J]. Journal of Shandong University (Health Sciences), 2024, 62(12): 43-48. |
| [11] | LI Jinquan, GAO Meifang, YAN Fei, DONG Ming. Frequency and risk factors of muscle cramp in 136 cases of type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 20-24. |
| [12] | XU Tianqi, CHANG Na, ZHANG Shuai, LI Sha, JIAO Bingxuan, YU Xinxin, WANG Ximing. Identification of carotid high-risk plaques by non-alcoholic fatty liver disease based on CTA [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 36-43. |
| [13] | HAN Mei, MENG Weijing, TAO Zikun, YANG Xi, XU Yaqi, MU Huaxia, BU Weixiao, WANG Suzhen, SHI Fuyan. Causal mediation analysis with multiple-mediator of hypertension and depression between type 2 diabetes mellitus and cognitive function based on G-computation [J]. Journal of Shandong University (Health Sciences), 2023, 61(10): 101-108. |
| [14] | WU Hong, ZHANG Zhengduo, TANG Yanjin, QI Shaojun, GAO Xibao. Potential intervention effects of 5-methyltetrahydrofolate on atherosclerosis in rats [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 6-13. |
| [15] | LI Tao, YANG Chunlin, DU Tong, LI Heng, WANG Congcong, LI Xiaoli, DUAN Ruisheng,ZHANG Peng. Effects of diabetes mellitus on the subsets and function of NK cells in myasthenia gravis [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 31-36. |
|
||